Market Value349,225,000
Total Holdings39
File Date2016-08-15
Original Filing (Click here)

All hedge funds or institutions that manage over $100M are required by the SEC to file quarterly reports on their holdings. These reports are called 13F reports. However, the filings are required the following quarter from the reporting period, which means that by the time the filing is made (and we see them), the information could be five months old.

For funds with long term positions that make few trades, the holdings might closely resemble their current holdings, even after several months. However, for funds that have high turnover, the holdings data we see might differ significantly from their current holdings. Institutions are required to report CALL and PUT options, and those positions are identified in the table. However, they are not required to report short positions.

Click the link icon to see the full transaction history.

Upgrade to unlock premium data and export to Excel .

Security Imputed
Share Price
Prev
Shares
Current
Shares
Change
(Percent)
Prev Value
(USD x1000)
Current Value
(USD x1000)
Change
(Percent)
CNXR / Connecture, Inc.
PLXP / PLx Pharma Inc.
PRTK / Paratek Pharmaceuticals Inc.
MCRB / Seres Therapeutics, Inc. Put
CLBS / Caladrius Biosciences Inc
XNCR / Xencor, Inc.
US88165N2045 / Tetraphase Pharmaceuticals, Inc.
RPTP / Raptor Pharmaceutical Corp.
OCRX / Ocera Therapeutics, Inc.
ADMS / Adamas Pharmaceuticals Inc
RVNC / Revance Therapeutics, Inc.
EGRX / Eagle Pharmaceuticals, Inc.
DERM / Journey Medical Corporation
0PP / Portola Pharmaceuticals Inc
LIFE / aTyr Pharma, Inc.
ARDM / Aradigm Corp.
SRPT / Sarepta Therapeutics, Inc. Call
ZGNX / Zogenix Inc
SIOX / Sio Gene Therapies Inc.
CMRX / Chimerix, Inc.
ARCT / Arcturus Therapeutics Holdings Inc.
STRM / Streamline Health Solutions, Inc.
0PP / Portola Pharmaceuticals Inc Call
VNDA / Vanda Pharmaceuticals Inc.
ADVM / Adverum Biotechnologies, Inc.
451731103 / Ignyta, Inc.
ICPT / Intercept Pharmaceuticals Inc Put
AMRN / Amarin Corporation plc - Depositary Receipt (Common Stock)
APYX / Apyx Medical Corporation
SGYPQ / SYNERGY PHARMACEUTICALS INC DEL
AUPH / Aurinia Pharmaceuticals Inc.
VCEL / Vericel Corporation
ACAD / ACADIA Pharmaceuticals Inc.
US33830X1046 / Five Prime Therapeutics Inc
ARDX / Ardelyx, Inc.
EXEL / Exelixis, Inc.
TENX / Tenax Therapeutics, Inc.
FOMX / Foamix Pharmaceuticals Ltd.
ASND / Ascendis Pharma A/S - Depositary Receipt (Common Stock)
BLUE / bluebird bio, Inc.
RIGL / Rigel Pharmaceuticals, Inc.
ITCI / Intra-Cellular Therapies, Inc.
SAGE / Sage Therapeutics, Inc.
ENTA / Enanta Pharmaceuticals, Inc.
VIRX / Viracta Therapeutics, Inc.
NBIX / Neurocrine Biosciences, Inc.